about
Another explanation for the low allergy rate in the rural Alpine foothillsThe two sides of the "endotoxin coin"Therapeutic effects of orally administered CJLP55 for atopic dermatitis via the regulation of immune response.Acinetobacter baumannii infection inhibits airway eosinophilia and lung pathology in a mouse model of allergic asthmaCow's milk allergy: a complex disorder.99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: controversial aspects of the 'hygiene hypothesis'.Asthma and atopy - the price of affluence?Atopic dermatitis and the 'hygiene hypothesis': too clean to be true?Toxoplasma gondii infection induces suppression in a mouse model of allergic airway inflammationEffects of probiotics on atopic dermatitis: a randomised controlled trial.Lactobacillus plantarum CECT 7315/7316 intake modulates the acute and chronic innate inflammatory response.Epigenetic inheritance of fetal genes in allergic asthma.Can we prevent allergy?Immunomodulation and immunodeficiency.Dietary treatment of childhood atopic eczema/dermatitis syndrome (AEDS).TLR4, 5, and 9 Agonists Inhibit Murine Airway Invariant Natural Killer T Cells in an IL-12-Dependent Manner.Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates immunoglobulin levels and cytokines expression in whey proteins sensitised mice.Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCG.Atopic dermatitis-mitigating effects of new Lactobacillus strain, Lactobacillus sakei probio 65 isolated from Kimchi.TLR ligands of ryegrass pollen microbial contaminants enhance Th1 and Th2 responses and decrease induction of Foxp3(hi) regulatory T cells.Tolerability and clinical outcome of coseasonal treatment with Escherichia coli strain Nissle 1917 in grass pollen-allergic subjects.The effects of various doses of bacterial lipopolysaccharide on the expression of CD63 and the release of histamine by basophils of atopic and non-atopic patients.Probiotics as additives on therapy in allergic airway diseases: a systematic review of benefits and risks.Modulation of mucosal/systemic antibody response after sublingual immunotherapy in mite-allergic children.Bacillus clausii effects in children with allergic rhinitis.Investigations on anti-Aspergillus properties of bacterial products.Evaluation of quantification methods of occupational endotoxin exposure.The inverse association of salmonellosis in infancy with allergic rhinoconjunctivitis and asthma at school-age: a longitudinal study.Decorating and loading ghosts with allergens for allergen immunotherapy.Usefulness of mycobacteria in redirecting the immune response in atopic disease.Spreading excellence in allergy and asthma: the GA2 LEN (Global Allergy and Asthma European Network) project.The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite.Hypothesis: urbanization and the allergy epidemic - a reverse case of immunotherapy?Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination
P2860
Q24813551-F2B5EAFB-70A1-4917-9FF7-F02BF4926A7FQ28397276-725B4923-863E-4463-B888-E7BC858D7563Q33614723-FA128E5C-03E2-42BF-9522-1C40249F5983Q33971195-EB130172-349F-4CD1-83EC-31F583B47CBAQ33992511-67ED1BAF-988C-4F04-A795-4FFA31E5CBBDQ34111856-5153AED9-9DF1-44A5-927D-11AEE5ADD94FQ34294918-C4138772-8CC9-42E8-9D1D-E21B3ABFA6F5Q34396961-3B0F080F-8CE3-4415-B788-002FEACB2E0EQ34405154-FE8B2AA8-15CB-4AE0-B880-9869E6920622Q35284723-116ADDA5-ECE2-4754-81BC-61853B713655Q35435106-883B9C62-A3A9-4AAA-B806-3E3A7F93F40DQ35649230-72D065C6-7FDA-43B4-A36D-104AB1A7CB62Q35649234-06B8F5C0-8002-4190-AE01-449244BBAAEFQ35696729-F10B2DD5-0582-4C0A-982D-6A0568ACDC91Q35831650-0B231B4F-37A0-4067-9F7A-047C5F5DC3D2Q36177350-C2F8BE09-879C-4E7C-B58A-FE1F4A8D8BD9Q38828414-313CEEC9-714F-433A-8D41-ADC3AF7D1BD5Q38959491-85720357-40FF-479C-B5A1-D3AD582F3681Q39162477-B910F49C-9FAD-48E6-95A3-7EA2A78559D5Q39226435-DE212652-0BBE-4471-A970-6578BC68614EQ39312563-2D909628-10A9-4534-931B-921B6387153BQ40071892-EE60C98A-E77A-4F6D-ABB2-F1EAC3F60CC6Q42089986-EBA75CA7-218D-4CC2-B4A1-FCB27F71629BQ44648897-080BCCDF-8254-4AD9-A682-04AEA3641C30Q46424941-E825E1B5-0C0F-478F-AB32-9AA23B1BAD48Q46699464-710ACF11-C639-4B82-BC9F-79F02E5C11A0Q46952381-8799014F-D79F-45E0-8757-B1742E1BDE87Q47819834-16D903C1-D409-4661-A7A8-20CFC1C04F76Q47937079-DFA419C6-549F-4746-8948-7F574B1F4682Q48014313-EDE292B6-C112-49B1-8223-3285F4147371Q49114469-D81E2BD5-2882-4FC9-9B88-5AF50C865530Q53285097-7FA39117-E13C-48C6-8B4B-960AB7167343Q57402096-C85428BC-C8D6-4A60-9A6E-1F25A62D245DQ57697885-42BD6B4D-3020-4E5B-9D1A-2F110F159629
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Microbial products in allergy prevention and therapy.
@ast
Microbial products in allergy prevention and therapy.
@en
type
label
Microbial products in allergy prevention and therapy.
@ast
Microbial products in allergy prevention and therapy.
@en
prefLabel
Microbial products in allergy prevention and therapy.
@ast
Microbial products in allergy prevention and therapy.
@en
P2093
P2860
P50
P1433
P1476
Microbial products in allergy prevention and therapy
@en
P2093
B Bjorksten
EAACI Task Force 7
H-J Malling
J Bousquet
P M Matricardi
P2860
P304
P356
10.1034/J.1398-9995.2003.00175.X
P577
2003-06-01T00:00:00Z